Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
08/2009
08/12/2009EP2088136A1 Process for production of hydroxyadamantaneamine
08/12/2009EP1359890A4 Primary intermediates for oxidative coloration of hair
08/12/2009CN101506145A Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
08/12/2009CN101503365A Preparation of venlafaxine intermediate 1-[2-amino-1-(4-methoxy phenyl)ethyl] cyclohexanol
08/12/2009CN100526277C Method for the treatment or prevention of lower urinary tract symptoms
08/12/2009CN100526265C Method for selective reduction of aromatic compounds
08/11/2009US7572778 recognize and bind the tubulin site: antitubulin; useful for treating pathological states which arise from or are exacerbated by cell proliferation as anticancer and/or antiangiogenic activity
08/11/2009US7572463 Oral dosage forms
08/11/2009CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's)
08/11/2009CA2335685C Benflumetol derivatives, intermediates thereof and their use against parasitical protozoa and trematodes
08/06/2009US20090198080 Method for the preparation of aryl ethers
08/06/2009US20090198035 Polyether polyamine agents and mixtures thereof
08/05/2009EP1186594B1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
08/05/2009CN100522910C Fluorocombretastatin and derivatives thereof
08/04/2009US7569728 as charge transport materials in electronic devices; organic light emitting diodes; as monomers to create homopolymers or copolymers of polyamines
07/2009
07/30/2009CA2712222A1 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
07/29/2009EP2081885A2 Improved processes for preparing venlafaxine base and salts thereof
07/29/2009EP1999103B1 Ethanolamine glyceryl ethers
07/28/2009US7566806 By reaction of iodide-terminated fluoroether compound with alkylamine compound; improved flexiblity; industrial scale
07/28/2009US7566688 Detergent composition
07/28/2009CA2356552C New reagent for labelling nucleic acids
07/23/2009WO2009090669A2 A process for the preparation of 5-chloro-2(2,4-dichlorophenoxy) aniline
07/23/2009WO2009089680A1 Method of modulating membrane potential of a cell
07/23/2009WO2008087421A3 Male contraceptive
07/23/2009US20090184294 Novel macromolecular antioxidants comprising differing antioxidant moieties: structures, methods of making and using the same
07/22/2009EP2079678A2 Selective tr-beta 1 agonist
07/22/2009CN101486660A Preparation of 2,2-bis[4-(2-trifluoromethyl-4-aminophenoxy)phenyl] propane
07/22/2009CN101486659A Alpha 1-adrenalin receptor antagonist, and preparation and medical use thereof
07/22/2009CN100516454C Method of controlling asphaltene precipitation in a fluid
07/22/2009CN100516044C Biphenyl derivatives and organic electroluminescent device using the same
07/22/2009CN100516024C Amino-propanol derivatives
07/21/2009US7563931 Process for preparation of phenethylamine derivatives
07/21/2009US7563806 Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
07/21/2009US7563548 high charge-transporting ability; prepared without using a phosphorus reaction reagent; friendly to global environment; unsaturated naphthylamines
07/21/2009CA2419463C Primary intermediates for oxidative coloration of hair
07/16/2009US20090181878 Compounds for a controlled release of active molecules
07/15/2009EP2077990A1 Method for the continuous separation by distillation of mixtures that contain morpholine (mo), monoaminodiglycol (adg), ammonia and water
07/15/2009EP2077989A1 Method for producing electronic grade 2,2'-aminoethoxyethanol
07/15/2009EP2077988A1 Process for the synthesis of aryloxypropylamine and heteroaryloxypropylamine
07/15/2009EP1529037B1 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
07/15/2009EP1414783B1 Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions
07/15/2009CN101484413A Process for preparing gabapentin
07/14/2009USRE40851 3,3-diphenylpropylamines, their use and preparation
07/14/2009US7560586 Acid and ester compounds and methods of using the same
07/14/2009US7560582 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
07/14/2009CA2464648C Process for resolution of tamsulosin
07/14/2009CA2362365C Method for the racemization of optically active amines
07/09/2009US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
07/09/2009US20090176305 Compounds and methods for treating breast cancer and other diseases
07/08/2009EP2076125A2 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
07/08/2009CN101475500A Clean production method of 3-amino-4-methoxytoluene
07/08/2009CN101475499A Rare earth-N, N'-(2-hydroxy-3-methoxybenzene methyl) ethylene diamine complex single crystal and preparation thereof
07/08/2009CN100510974C Electrophotographic photoreceptor and image forming apparatus including the same
07/08/2009CN100509783C Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
07/08/2009CN100509755C Method for preparing 3-aryloxy-3-aryl propylamine
07/02/2009WO2009080655A1 Preparation of phenethyl tertiary amine derivatives
07/01/2009CN101468952A Preparation of 4,4'-diaminodiphenyl ether
07/01/2009CN100506785C Quaternary ammonium compound, method for production thereof, and therapeutic agent for cerebrovascular disorder and heat disease
07/01/2009CN100506776C NK1 antagonists
06/2009
06/30/2009US7553971 Aryl aniline β2 adrenergic receptor agonists
06/25/2009US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma
06/25/2009US20090163589 calcium receptor antagonists such as 3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxyl]-phenyl}-propionic acid, used to increase serum parathyroid hormone levels in mammals
06/24/2009EP2072496A1 Method for producing high-purity quaternary ammonium salt
06/24/2009EP2072495A1 Preparation of phenethyl tertiary amine derivatives
06/24/2009CN101462972A N, N'- disubstituted 4,4'-diaminodiphenyl ether compound and preparation thereof
06/24/2009CN101462971A High-purity key intermediate for preparing formoterol and preparation thereof
06/24/2009CN101462970A Process for synthesizing chiral methoxybenzylamine
06/24/2009CN101462969A Process for synthesizing 1- methylamino-1-methoxy-2-nitroethylene
06/23/2009US7550550 aminated polyols from alkylene glycol adducts; increased working time; curing agents for epoxy resins; preparing polyureas from the diamines and diisocyanates; composite blades for wind-driven turbines
06/23/2009US7550511 amino alcohols; selective ribonucleic acid (RNA) binding agents; detecting the binding of small molecules to T-box antiterminator model mRNAs; screening for microbiocidal drug targets; use disinfecting; antiviral, anti-HIV; e.g. use of 1,2-dihydroxy-3-amino-4-phenylbutane
06/18/2009US20090156863 Atomoxetine hydrochloride pure crystalline form
06/18/2009US20090156685 (r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
06/18/2009US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction
06/17/2009EP1322592B2 Substituted 1-aminobutan-3-ol derivatives
06/17/2009CN101456820A Alkoxyl aniline prepared by amino-phenol
06/17/2009CN100500643C Chemical synthesis of 3,4,5-trioxyaniline
06/16/2009US7547805 reacting tert-butylamine with diethylene glycol at elevated temperature and pressure in the presence of a hydrogenation catalyst containing a catalytically active reduced nickel (excluding platinum and palladium ) dispersed on a support such as silica or zeolite type MCM-41
06/16/2009US7547802 Compounds for the treatment of metabolic disorders
06/16/2009US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders
06/16/2009CA2447640C Substituted anilide derivative, intermediate thereof, agricultural and horticultural chemical and its usage
06/16/2009CA2202032C Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/09/2009US7544312 Charge transport compositions and electronic devices made with such compositions
06/09/2009CA2355720C New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
06/09/2009CA2251331C Calcilytic compounds
06/04/2009WO2009068177A1 DERIVATIVES OF 4-(2-AMINO-1 -HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
06/04/2009WO2009054916A3 Oligomer conjugates of lidocaine and its derivatives
06/04/2009US20090143622 Method For The Synthesis Of Substituted Formylamines And Substituted Amines
06/04/2009US20090143583 Transfection reagents
06/04/2009US20090143467 Anticancer agents based on regulation of protein prenylation
06/04/2009CA2706333A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor
06/03/2009EP2065358A1 The prepartion and the use of ethoxy combretastatins and their prodrugs
06/03/2009EP2064174A1 Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
06/03/2009CN101448777A Fragrance precursor
06/03/2009CN101444496A Compounds for the treatment of metabolic disorders
06/02/2009CA2464917C Racemic tamsulosin free base and methods of making the same
06/02/2009CA2362185C Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof
06/02/2009CA2334308C Hyperforin derivatives, the use thereof and formulations containing them
05/2009
05/28/2009WO2009067597A1 4- (or 5-) substituted catechol derivatives
05/28/2009WO2009065406A2 Novel cyclic hydrocarbon compounds for the treatment of diseases
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 140